What is Pazopanib 400 mg?
Pazopanib 400 mg is a prescription medication used to treat certain types of cancer, specifically kidney cancer and soft tissue sarcoma. It contains pazopanib as its active ingredient, a targeted therapy drug that plays a crucial role in inhibiting cancer growth.
Manufactured by GlaxoSmithKline Pharmaceuticals Ltd, Pazopanib 400 mg is designed to help patients by slowing or stopping the progression of tumors associated with these cancers. It is an important medicine in oncology, prescribed by healthcare professionals in Canada and other countries.
Uses of Pazopanib 400 mg
- Treatment of advanced kidney cancer (renal cell carcinoma), where everolimus is also used
- Management of soft tissue sarcoma after chemotherapy failure with agents such as gemcitabine
How Pazopanib 400 mg Works
Pazopanib works by blocking angiogenesis, the process through which tumors develop new blood vessels. It inhibits specific proteins called tyrosine kinases involved in tumor growth and blood vessel formation. By targeting these pathways, Pazopanib 400 mg helps starve cancer cells of nutrients and oxygen, thereby limiting tumor expansion.
Benefits of Pazopanib 400 mg
- Effective in controlling kidney cancer and soft tissue sarcoma
- Delays progression of advanced tumors
- Oral administration allows convenient dosing
- Improves patient quality of life by managing cancer symptoms
- Supported by clinical research and oncologist recommendations
Dosage and Administration
Pazopanib 400 mg is usually taken once daily on an empty stomach, at least one hour before or two hours after meals. It is important to follow the prescribing doctor’s instructions carefully. The dosage may be adjusted depending on individual tolerance and response.
Patients should swallow the tablet whole with water and avoid grapefruit or grapefruit juice, which can interfere with the medicine’s effectiveness. Regular medical check-ups are necessary to monitor the treatment progress and manage any side effects, and angiogenesis inhibitors explained for patients clarifies how this type of therapy works.
Who Should Use Pazopanib 400 mg?
Pazopanib 400 mg is recommended for adults diagnosed with advanced kidney cancer or soft tissue sarcoma who require targeted therapy. It is especially suitable for patients whose cancers have progressed after initial treatments.
Patients under oncologist supervision and those able to comply with treatment and follow-up protocols are good candidates for this medication.
Who Should Avoid Pazopanib 400 mg?
Pazopanib 400 mg is not suitable for individuals with known hypersensitivity to pazopanib or its ingredients. It should be avoided by pregnant or breastfeeding women due to potential risks to the fetus or infant.
Patients with severe liver impairment, uncontrolled high blood pressure, or recent heart problems should consult their doctor before using this medicine. It is also contraindicated for individuals taking certain medications that may interact adversely.
Side Effects
- High blood pressure (hypertension)
- Diarrhea
- Hair color changes
- Nausea
- Fatigue
- Loss of appetite
- Liver function abnormalities
- Mouth sores
- Headache
- Dizziness
- Abdominal pain
Safety Advice
- Inform your doctor of all current medications and supplements
- Regularly monitor blood pressure while on treatment
- Avoid grapefruit and its juice
- Report any signs of liver problems, such as yellowing skin or eyes
- Do not stop taking the medication without consulting your healthcare provider
- Practice contraception to avoid pregnancy during treatment
- Attend all scheduled medical check-ups for blood tests and health monitoring
Drug Interactions
- Warfarin and other blood thinners
- CYP3A4 inducers and inhibitors (e.g., ketoconazole, rifampin)
- Simvastatin and other statins
- Medications affecting heart rhythm
- Other anticancer drugs such as sorafenib
Storage Instructions
Store Pazopanib 400 mg tablets in a cool, dry place below 30°C. Keep the medication in its original packaging to protect it from moisture and light. Ensure it is kept out of reach of children and pets.
Where to buy Pazopanib 400 mg in Canada?
Pazopanib 400 mg is available through licensed pharmacies and oncology clinics across Canada. It is important to obtain this medication with a valid prescription from a healthcare professional. Many Canadian patients prefer buying from reputable pharmacies to ensure authenticity and proper storage.
Online pharmacies serving Canadian customers may also offer Pazopanib 400 mg, but always verify the source and consult your oncologist before purchasing.
Frequently Asked Questions (FAQ)
Is Pazopanib 400 mg available in Canada?
Yes, Pazopanib 400 mg is available in Canada with a prescription. It is supplied by authorized pharmacies and specialized cancer treatment centers.
What is the price of Pazopanib 400 mg in Canada?
The price of Pazopanib 400 mg can vary depending on the supplier and insurance coverage. It is best to check with Canadian pharmacies or your healthcare provider for current pricing details.
What happens if I miss a dose?
If you miss a dose of Pazopanib 400 mg, take it as soon as you remember unless it is close to the next scheduled dose. Do not double the dose to compensate. Consult your doctor for personalized advice.
Where can I find Pazopanib 400 mg for sale?
You can find Pazopanib 400 mg at licensed pharmacies and cancer specialty clinics in Canada. Online pharmacies may also stock it, but ensure they are certified and legitimate.
Can I take Pazopanib 400 mg with other medications?
Some medications may interact with Pazopanib 400 mg. Always inform your doctor about all medicines and supplements before starting treatment to avoid harmful interactions.
Are there dietary restrictions when using Pazopanib 400 mg?
Yes, avoid grapefruit and grapefruit juice as they can affect how Pazopanib works in your body. Take the medication on an empty stomach for best results.
What monitoring is required during treatment?
Regular blood tests, liver function checks, and blood pressure monitoring are essential during treatment with Pazopanib 400 mg. Your healthcare provider will schedule these as needed.
Conclusion
Pazopanib 400 mg is a vital targeted therapy option for patients with advanced kidney cancer and soft tissue sarcoma. Manufactured by GlaxoSmithKline Pharmaceuticals Ltd, this medication helps inhibit tumor growth and manage cancer progression effectively. When used under medical supervision with proper dosing and monitoring, Pazopanib 400 mg offers significant benefits for cancer management in Canada and beyond, with a lower strength available as Pazopanib 200 mg.
Leave A Review